Volume Insights on Nasogastric Tube Sector

The global nasogastric tube sector volume projection was valued at 177 million units in 2023 and is projected to reach 278 million units by 2035, registering a CAGR of 3.8% from 2024.

Volume Insights - A Strategic Overview

Allied Market Research announces the release of its comprehensive analysis of global nasogastric tubes. Nasogastric tubes are essential medical devices used for feeding, medication administration, and gastric decompression in patients unable to consume food orally. The growing burden of gastrointestinal disorders, neurological diseases, and post-surgical recovery needs is propelling the demand for nasogastric tube sector sales.  

Furthermore, silicone-based nasogastric tubes are becoming more and more popular in the industry because of their improved longevity, decreased patient discomfort, and biocompatibility, especially in critical care and long-term care facilities. Silicone-based tubes are generally adopted as the preferred option. The safety and effectiveness of these tubes are further improved by the incorporation of anti-reflux valves and radiopaque materials, which lowers the possibility of complications like aspiration and misplacement. 

The report highlights nasogastric tube sector volume projection and the growing demand across hospitals, long-term care facilities, and home healthcare settings for various nasogastric tube sector volume application. Product shipments have surged, fueled by advancements in medical tubing materials, increase in geriatric population, and rise in awareness about enteral feeding. The steady growth in shipments is attributed to the rising adoption of home care services, increasing chronic disease prevalence, and government initiatives supporting technologies.  

The moderate growth in shipments is attributed to the rise in adoption of enteral feeding, and increase in chronic disease prevalence.The global volume of nasogastric tubes is expected to grow from 176.82 million units in 2023 to 277.56 million units by 2035, registering a CAGR of 3.8% during the forecast period. The rapid expansion is supported by innovations in product development such as the anti-reflux valves and radiopaque materials, surge in the prevalence of gastrointestinal diseases, and rise in demand for enteral feeding due to increase in surgical volume. 

Regional Nasogastric Tube Sector Volume Growth

Asia-Pacific dominates the nasogastric sector with 42% share in 2023 and a 4.6% CAGR, while North America, Europe, and LAMEA show strong growth at 2.9%, 3.2%, and 3.7% CAGR, respectively, driven by regional nasogastric tube trends and enteral feeding awareness. 

The regional analysis highlights significant variations in adoption trends and sector potential across the globe. Asia-Pacific leads the sector, contributing over 42% of the total volume in 2023 and expected to grow at a CAGR of 4.6%, increasing hospital admissions, a large elderly population, requiring IV therapy, and government initiatives to enhance healthcare infrastructure.

North America led by the U.S. and Canada, is projected to maintain steady growth at a 2.9% CAGR, and Europe follow closely, with 3.2% CAGR with strong growth fueled by an aging population, technological advancements, improved patient care systems, thereby driving the nasogastric tube sector growth. LAMEA growing with 3.7% CAGR is emerging as a high-growth region, benefiting from increased healthcare investments and a rising burden of gastrointestinal diseases. 

Nasogastric Tube Sector Volume Growth, By Region, 2023-2035 (Million Units) 

Source: AMR Analysis 

Nasogastric Tube Country Sector Sales

U.S. leads the nasogastric tube sector, projected to reach 34 million units and 46 million units by 2035 at 2.8% CAGR, respectively, while India (4.8% CAGR) and China (5.1% CAGR) emerge as high-growth sectors driven by chronic diseases surge and aging population. 

The report identifies the U.S. as the largest contributor to the nasogastric sector in terms of volume. U.S., with its extensive healthcare infrastructure and growing emphasis on enteral feeding development, is projected to reach by 48 million units by 2035 at 2.8% CAGR. U.S. remains an important player in North America, which is growing at a steady 2.9% CAGR and accounting for 56 million units by 2035. 

Emerging sectors such as China, India, and Brazil are expected to drive significant growth due to their increasing focus on chronic disease. India and China, benefiting from government-led initiatives and the adoption of modern technology, are expected to cite a CAGR of 4.8% and 5.1%, respectively, the highest among major countries. Brazil, representing Latin America, is projected to grow at a CAGR of 4.2%, supported by its expanding healthcare industry and favorable policies. 

Nasogastric Tube Sector Volume Share, By Country, 2023-2035 (Million Units)

Source: AMR Analysis 

Key Highlights by Stakeholders

Highlighting the significance of this report, Anshul Mishra, Associate Vice-President of Allied Market Research, stated, “The rising demand for nasogastric tubes in chronic disease affected patients remains opportunistic. Our latest report captures the sector's dynamics, providing actionable insights for stakeholders aiming to capitalize on this opportunity.” 

He further added, “Asia-Pacific, with its rapid healthcare expansion, remains the most promising region. At the same time, advancements in tube material and design technologies in North America and Europe are driving steady growth in these sectors. With this comprehensive analysis, we aim to empower our clients with the knowledge needed to make informed business decisions.” 

Nasogastric Tube Sector Volume Trends

The report also emphasizes the growing role of nasogastric tubes in addressing the need for feeding critical patients and patients with swallowing difficulties. This nasogastric tube sector trend is pushing manufacturers to develop silicone-based, polyurethane, NG tubes that enhance patient comfort while minimizing infection risks. The demand for post-operative nutritional support, the growing incidence of neurological diseases, and gastrointestinal disorders have all contributed to the increase in adoption of the nasogastric tube sector volume forecast.

Nasogastric tubes are mostly used in hospitals, long-term care settings, and home healthcare settings. Enteral feeding is becoming more significant for management of critically ill and chronic patients. Thus, demand is being further increased by the growing number of geriatric population around the world who frequently need nutritional assistance because of chronic diseases and swallowing issues, thereby driving the nasogastric tube sector growth. 

Furthermore, the study explores the potential impact of global healthcare challenges, including aging populations, rising chronic disease prevalence, and economic healthcare disparities. With increasing demand for home-based healthcare and long-term nutritional support, the use of nasogastric tubes is expected to rise in both hospital and home settings, further boosting nasogastric tube sector size. The heightened focus on nutritional management, cost-effective enteral feeding solutions, and better patient outcomes positions NG tubes as a critical component of modern healthcare strategies. 

Medical device manufacturers should use the report’s insights to grab new opportunities and plan ahead. 

About Allied Market Research

Allied Market Research is a full-service market research and business consulting firm, which provides actionable insights and strategic recommendations to help clients make informed decisions and achieve sustainable growth. For more inquiries, please visit alliedmarketresearch.com